PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-117.41%
Both yoy net incomes decline, with CRK at -130.92%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-3.65%
Both reduce yoy D&A, with CRK at -77.26%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-300.00%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-34.78%
Both cut yoy SBC, with CRK at -0.86%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
-2135.29%
Both reduce yoy usage, with CRK at -33.50%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-1001.95%
AR is negative yoy while CRK is 214.45%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
141.16%
A yoy AP increase while CRK is negative at -156.21%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
-2135.29%
Both reduce yoy usage, with CRK at -367.14%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
33766.67%
Well above CRK's 148.96%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-7.43%
Negative yoy CFO while CRK is 18.13%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-7.13%
Both yoy lines negative, with CRK at -17.73%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-1293.71%
Both yoy lines negative, with CRK at -99.97%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
200.00%
We have some outflow growth while CRK is negative at -99.97%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-2.96%
Both yoy lines negative, with CRK at -395.59%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-6900.00%
We cut debt repayment yoy while CRK is 61.70%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
35.69%
Buyback growth of 35.69% while CRK is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.